Search
"What Can We Do About the Hardest Patients?" Freakonomics, M.D. podcast
HSI Professor Joseph Doyle is interviewed on Freakomomics, M.D. podcast
How game theory explains ‘irrational’ behavior
By
A new book explores how game theory explains seemingly irrational behavior, from tastes in food to how people donate to charity.
Crowdsourcing to better forecast drug approvals
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
Growing importance of academia in accelerating biomedical innovation
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
Gamification techniques to improve online teaching and learning
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
Our People
Our faculty researchers have deep expertise in operations management, organizational behavior, system dynamics, accounting, marketing, and finance.
About Us
HSI's mission is to improve health by discovering transformative and sustainable innovations through research and education with leaders in the field.
Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.